Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Cancers|October 14, 2022
Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic ReviewMarina Triquell, Miriam Campistol, Ana Celma, et al.
Urologia Internationalis|March 11, 2010
Preoperative prediction of pathologically insignificant prostate cancer in radical prostatectomy specimens: the role of prostate volume and the number of positive coresCarles X Raventós, Anna Orsola, Inés de Torres, et al.
Journal of Endourology|August 19, 2014
Effects of holmium laser enucleation of the prostate on sexual functionJosé Placer, Carlos Salvador, Jacques Planas, et al.
BJU International|February 18, 2009
The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressivenessJuan Morote, Cristobal Ramirez, Esther Gómez, et al.
Clinical Genitourinary Cancer|December 5, 2017
Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist TherapyJuan Morote, Inma Comas, Jacques Planas, et al.
European Journal of Radiology|February 19, 2021
The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trialLucas Regis, Aina Salazar, Jacques Planas, et al.
Scandinavian Journal of Urology|January 11, 2019
The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?Lucas Regis, Ana Celma, Jacques Planas, et al.
BJU International|June 25, 2009
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosisJacques Planas, Enrique Trilla, Carles Raventós, et al.
Cancers|August 26, 2022
Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical ProstatectomyMarina Triquell, Lucas Regis, Mathias Winkler, et al.
BJU International|June 30, 2009
Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TURAnna Orsola, Lluís Cecchini, Carles X Raventós, et al.
Pageof 8